alexa AV-Fistula or Tunnelled Catheter for Haemodialysis? | Open Access Journals
ISSN: 2472-1220
Journal of Kidney
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

AV-Fistula or Tunnelled Catheter for Haemodialysis?

Thomas Ryzlewicz*

Dialysis Centre, ViaMedis Riesa, Germany

*Corresponding Author:
Thomas Ryzlewicz
ViaMedis Kidney Centre, Robert- Koch-Strasse 30
D-01589, Riesa, Germany
Tel: +49 172 836 66 25
E-mail: thomas.ryzlewicz@web.de

Received date: November 27, 2015 Accepted date: November 28, 2015 Published date: December 07, 2015

Citation: Ryzlewicz T (2015) AV-Fistula or Tunnelled Catheter for Haemodialysis?. J Kidney 1:e102. doi:10.4172/2472-1220.1000e102

Copyright: © 2015 Ryzlewicz T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Kidney

Editorial

When Haemodialysis started by Kolff and Alwall in the forties, it was a long way of two and a half decade, to transfer this new treatment to the first regular CKD-5 Patients. The lack of the vascular access was the one and only reason. To start, the first access was the Scribner-Quinton Shunt, but this was more or less a makeshift. In 1962 James Cimino published, that Haemodialysis could be done using two different veins(!). Kenneth Appel (together with James Cimino) had sewed in 1966 the first 3 mm anastomosis between an artery and a superficial vein, that later on was named Cimino-Brescia-Fistula. This invention of this vascular access (together with the design of a single-pass dialysis generator (S. Shaldon) using Acetate concentrate) had shifted the trials of Dialysis into a regular clinical treatment. The final version of the Cimino-Fistula had done in 1967 (side to end anastomosis), so the Haemodialysis had spread all over in the world.

In 1988 Francis (Royal Free, London) had combined Shaldon’s Catheter with the top of a Tenckhoff Catheter for a patient planed for living donor transplantation in order to bridge a half year Haemodialysis treatment. This catheter of Francis had tunnelled, the tip had placed in the right atrium of the heart. There was total sterile handling. After six month, the living donor transplantation had done and the Francis Catheter had taken off. Learning from this: There was total sterile handling and a limited time of treatment.

The problem of this decade concerning the Vascular Access for CKD-5 Patients? It is the wide spread use of tunnelled Dialysis Catheters (up to 70% in the US (>USRDS ESRD Database)) in comparison to the classical Cimino-Fistula (19%). The preference Dialysis Catheters results in reasons of infection in 30% of hospitalization. Easily an infection of a Dialysis Catheter can shift to a life threating complication, the sepsis. The wide spread use of Dialysis Catheters contradicts all serous recommendations of KDOQI/NKF Clinical Practice Guidelines, EDTA Best Practice Guidelines and of DOPPS Report concerning a vascular access for CKD-5 Patients. The Catheter Sepsis can shorten Patient’s life seriously. An infection of a Cimino-Fistula remains a local problem and - as there is no plastic - there is save handling.

Narender Goel had clearly shown, that in his study there was no referral from the nephrologists to the vascular surgeons to create a Cimino-Fistula or a PTFE graft. These patients in state of CKD-4 had treated by the nephrologists. But reaching the state of CKD-5, the majority of them had no vascular access! When you tell this context to a layman, he never would believe this! But this is clinical reality. Why can a bigger part of nephrologists neglect continuously these mentioned recommendations?

This behaviour of the prevalence of Dialysis Catheters as the Vascular Access is a serious point. It shows: The medical education does not reach an important part of nephrologists. So the Dialysis Providers will kindly asked to solve this problem. With a classical Cimino-Fistula, there is very low risk of infection. When there is a better quality of treatment (>this means here without a Catheter Infection), there is longer living of the patients. If the ethical reasons to improve the quality of treatment to reach an av-fistula for the majority of the CKD-5 Patients are not sufficient, perhaps the Providers of the Dialysis Centres can help to improve the quality of treatment.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 11th Global Nephrologists Annual Meeting
    Jun 26-28, 2017, London, UK
  • 2nd Annual Kidney Congress
    Aug 28-30, 2017, Philadelphia, USA
  • 16th European Nephrology Conference
    Oct 02-04, 2017, Barcelona, Spain
  • 16th International Conference on Nephrology
    Nov 02-03, 2017, Atlanta, USA

Article Usage

  • Total views: 7792
  • [From(publication date):
    December-2015 - May 29, 2017]
  • Breakdown by view type
  • HTML page views : 7750
  • PDF downloads :42
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version